Abstract:Background: Preterm birth associated with intrauterine inflammation (IUI) has been linked to alterations in postnatal immunity and severe inflammatory complications during infancy. However, the impact of IUI on late-onset sepsis (LOS), a leading cause of mortality and morbidity in preterm infants, remains unclear. This study aims to elucidate the effect of IUI on the incidence of LOS in preterm infants by analyzing cytokine levels and white blood cell differential counts in cord blood within 24 hours after birth. Methods: This retrospective cohort study was conducted at a single tertiary neonatal center. Infants born before 37 weeks of gestation between July 2020 and June 2022 were included. Late-onset sepsis (LOS) was defined as sepsis occurring after 72 hours of life during the birth hospitalization. Levels of 12 cytokines, including interleukin-1β (IL-1β), IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, tumor necrosis factor-α (TNF-α), interferon-α (IFN-α), and IFN-γ, were measured in cord blood using multiplex bead-based flow immunoassays. Clinical data were extracted from hospital databases. Peripheral white blood cell counts within 24 hours after birth were routinely recorded for preterm infants. Logistic regression analysis was used to assess the impact of cytokines and white blood cell counts on the incidence of LOS. Results: A total of 628 preterm infants were included in this study. The mean gestational age was 33.17 ± 2.25 weeks, and the mean birth weight was 1929.50 ± 516.77 grams. Of these, 42 infants (6.7%) developed late-onset sepsis (LOS). Compared to the non-LOS group, cord blood levels of IL-6 [127.81 (399.86) vs. 31.02 (127.48), p = 0.004] and IL-8 [130.37 (202.53) vs. 52.91 (101.43), p = 0.001] were significantly higher in the LOS group. No significant differences were observed in the levels of other cytokines between the groups. Peripheral neutrophil and monocyte counts were significantly lower in the LOS group [5.08 ± 3.46 vs. 8.14 ± 4.90, p < 0.001; 0.98 ± 0.56 vs. 1.37 ± 0.72, p = 0.001, respectively]. Multivariable logistic regression analysis revealed that elevated cord blood IL-6 levels and reduced peripheral neutrophil counts were associated with an increased risk of LOS, after adjusting for gestational age, gestational hypertension, and antenatal steroid use (aOR = 3.113, 95% CI: 1.239–7.819, p = 0.016; aOR = 0.340, 95% CI: 0.818–0.994, p = 0.038, respectively). Conclusions: Elevated cord blood IL-6 levels and low peripheral neutrophil counts on the first day after birth are associated with an increased risk of LOS in preterm infants. These findings suggest that intrauterine inflammation may have a lasting impact on immune system responses, potentially influencing susceptibility to infections later in life.

Immune Biomarkers at Birth Predict Lower Respiratory Tract Infection Risk in a Large Birth Cohort

Biomarkers detected in cord blood predict vaccine responses in young infants

Immunoinflammatory markers SIRI and NAR as predictors of respiratory distress syndrome and secondary infections in premature infants

Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth

Cord blood granulocyte levels are associated with severe bronchiolitis in the first year of life

Cord‐blood respiratory syncytial virus antibodies and respiratory health in first 5 years of life

Correlates of Protection Against Respiratory Syncytial Virus Infection in Infancy

Personalized infant risk prediction for severe respiratory syncytial virus lower respiratory tract infection requiring intensive care unit admission

Network Analysis Reveals Protein Modules Associated with Childhood Respiratory Diseases

Immunomodulatory Constituents of Human Breast Milk and Immunity from Bronchiolitis

Predictive Role of Maternal Laboratory Parameters and Inflammatory Scores in Determining Systemic Inflammatory Response Syndrome in Newborns at Birth

Birth characteristics as predictors of respiratory syncytial virus hospitalisation in newborns to optimise immunisation schedule

Transfer of Respiratory Syncytial Virus Prefusion F Protein Antibody in Low Birthweight Infants

Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age

Upper respiratory tract bacterial-immune interactions during respiratory syncytial virus infection in infancy

Amniotic fluid proteomic analysis identifies IL1RL1, APOE, and NECTIN4 as new biomarkers for preterm birth

Bedside clinical assessment predicts recurrence after hospitalization due to viral lower respiratory tract infection in young children

Maternal prenatal systemic inflammation indexes predicts premature neonatal respiratory distress syndrome

DNA Methylation signatures underpinning blood neutrophil to lymphocyte ratio during first week of human life

Intrauterine Inflammation Exposure May Increase the Risk of Late-Onset Sepsis in Premature Infants:A Retrospective Cohort Study

916. the Transfer of Maternal Antibodies and Dynamics of Maternal and Natural Infection-induced Antibodies Against RSV in Children: A Longitudinal Cohort Study